Please Wait.....
Report
UAE Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027
Market Report I 2023-02-01 I 75 Pages I TechSci Research
UAE generic drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of surging demand for affordable healthcare services. Increasing demand for medicines and drugs for chronic patients exposed to prolonged medication further demand generic drugs over branded drugs, thereby driving the growth of the UAE generic drugs market in the upcoming five years. Easier FDA approvals for generic drugs also support the growth of the UAE generic drugs market in the next five years.
Generic drugs are medicines that have the same active ingredients, same safety standards, are equally effective, and are of high quality as much as the branded drugs but are much cheaper than the branded drugs. The dosage, therapeutic activity, administration, and formulation of the generic drug are the same as the branded drugs. The major difference between the two is the cost of drugs and inert ingredients that give the drug its color, shape, or taste. Once the patent of the branded drug expires, generic drug manufacturers duplicate the chemical formulas of the branded drug to manufacture a generic drug. Manufacturing and patient use do not require extensive clinical trials to prove safety and efficiency. If the molecule formula and safety standards are followed during the manufacturing the drug is soon released in the market thus making the manufacturing process cost-efficient and thus the low prices of the drugs. Examples of generic drugs include "metformin". Metformin is a generic drug for the branded drug, "Glucophage" which is used for diabetes. Similarly, "metoprolol" is used for hypertension instead of "Lopressor".
Growing Pharmaceutical Industry Promises Market Growth
The UAE pharmaceutical industry is expanding rapidly due to surging demands for pharmaceutical products, increasing imports of pharmaceuticals to satisfy the surging demands as well as increased manufacturing of generic drugs by local manufacturers that further drives the growth of the UAE generic drugs market in the upcoming five years. According to government sources, the demand for pharmaceuticals in Dubai region alone would exceed 5 million, further, expansion is also expected due to the overall increasing population all over the country.
The pharmaceutical manufacturing landscape in UAE has been dominated by generic drug manufacturers and contract manufacturing organizations (for medical therapeutics). Although global giants are penetrating the market large number of manufacturing units for branded drugs are not yet flooding the country. The market players have made Dubai a regional hub due to a favorable tax environment, well-developed infrastructure, and a bustling labor force.
Increasing Chronic Diseases Instances Drive Market Growth
Increasing instances of chronic diseases like cardiovascular diseases, cancer, diabetes, etc. further drive the growth of the UAE generic drugs market in the upcoming five years. Due to cardiovascular diseases over 40% of deaths are caused every year in the UAE. Demands for the drugs for a prolonged period due to chronic conditions of the diseases further support the growing demand for generic drugs to reduce the treatment costs of the diseases. By the year 2021, the country had 6176 generic drugs being manufactured that cost less than 60% than the branded medicines making healthcare much more h affordable for the common population. The country had 16 factories ithe n medical and pharmaceutical industry and three others for intravenous fluids, laboratories, and medical supplies in 2021 and the count is increasing further. The government is also investing in outpatient healthcare services that aid the market, the value of UAE outpatient healthcare expenditure in 2020 was USD7.41 billion.
Market Segmentation
The UAE generic drugs market is segmented by type, mode of drug delivery, form, source, distribution channel, application, competitional landscape, and regional distribution. Based on type, the market is differentiated between small molecule generics and biosimilars. By mode of drug delivery, the market is further segmented into oral, topical, parenteral, and others. The form-based market is fragmented into a tablet, capsules, injections, and others. By source, the market is differentiated between in-house and contract manufacturing organizations. Based on distribution channels, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. By application, market segments are defined into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi region, Dubai region, Sharjah region, and the rest of UAE.
Company Profile
Gulf Pharmaceutical Industries (Julphar), Sanofi UAE, Sun Pharma Global FZE, Abbott Laboratories SA, Eli Lilly & Company UAE, Mylan UAE, and GlaxoSmithKline & Neopharma, among others is a partial list of major market players of the companies responsible for the growth of UAE generic drugs market.
Report Scope:
In this report, UAE generic drugs market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- UAE Generic Drugs Market, By Type:
o Small Molecule Generics
o Biosimilars
- UAE Generic Drugs Market, By Mode of Drug Delivery:
o Oral
o Topical
o Parenteral
o Others
- UAE Generic Drugs Market, By Form:
o Tablet
o Capsule
o Injection
o Others
- UAE Generic Drugs Market, By Source:
o In House
o Contract Manufacturing Organizations
- UAE Generic Drugs Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
- UAE Generic Drugs Market, By Application:
o Cardiovascular Diseases
o Diabetes
o Neurology
o Oncology
o Anti-Inflammatory Diseases
o Others
- UAE Generic Drugs Market, By Region:
o Abu Dhabi region
o Dubai region
o Sharjah region
o Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in UAE generic drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on UAE Generic Drugs Market
4. Voice of Customer
5. Executive Summary
6. UAE Generic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Small Molecule Generics v/s Biosimilars)
6.2.2. By Mode of Drug Delivery (Oral, Topical, Parenteral, Others)
6.2.3. By Form (Tablet, Capsule, Injection, Others)
6.2.4. By Source (In House v/s Contract Manufacturing Organizations)
6.2.5. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
6.2.6. By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)
6.2.7. By Company (2021)
6.2.8. By Region
6.3. Product Market Map
7. UAE Small Molecule Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mode of Drug Delivery
7.2.2. By Form
7.2.3. By Source
7.2.4. By Distribution Channel
7.2.5. By Application
8. UAE Biosimilar Generic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mode of Drug Delivery
8.2.2. By Form
8.2.3. By Source
8.2.4. By Distribution Channel
8.2.5. By Application
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. UAE Economic Profile
13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Gulf Pharmaceutical Industries (Julphar)
13.2.2. Sanofi UAE
13.2.3. Sun Pharma Global FZE
13.2.4. Abbott Laboratories SA
13.2.5. Eli Lilly & Company UAE
13.2.6. Mylan UAE
13.2.7. GlaxoSmithKline & Neopharma
14. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security